Alpha Tau Medical Ltd., (DRTS): Price and Financial Metrics Recent IPO


Alpha Tau Medical Ltd., (DRTS): $9.30

-2.30 (-19.83%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add DRTS to Watchlist
Sign Up

Industry: Biotech


Ranked

of

in industry

DRTS Stock Price Chart Interactive Chart >

Price chart for DRTS

DRTS Price/Volume Stats

Current price $9.30 52-week high $20.65
Prev. close $11.60 52-week low $4.68
Day low $9.20 Volume 105,598
Day high $11.85 Avg. volume 467,392
50-day MA $8.51 Dividend yield N/A
200-day MA $0.00 Market Cap 618.72M

Alpha Tau Medical Ltd., (DRTS) Company Bio


Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, engages in research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer In Israel and the United States. Its Alpha-DaRT technology used in clinical trials for skin, oral, pancreatic, and breast cancers; and preclinical studies for hepatic cell carcinoma, glioblastoma multiforme, lung cancer, and others. The company was incorporated in 2015 and is headquartered in Jerusalem, Israel.


DRTS Latest News Stream


Event/Time News Detail
Loading, please wait...

DRTS Latest Social Stream


Loading social stream, please wait...

View Full DRTS Social Stream

DRTS Price Returns

1-mo N/A
3-mo -21.19%
6-mo N/A
1-year N/A
3-year N/A
5-year N/A
YTD N/A
2021 N/A
2020 N/A
2019 N/A
2018 N/A
2017 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.4519 seconds.